Therapeutic Antibodies in Clinical Use and Leading Clinical Candidates (original) (raw)

Monoclonal antibody therapeutics and apoptosis

Daniel Pereira

Oncogene, 2003

View PDFchevron_right

Monoclonal antibody therapy of cancer

Grégory ADAMS

Nature Biotechnology, 2005

View PDFchevron_right

Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy

Ellen Vitetta

Cancer research, 1994

View PDFchevron_right

Antibody Therapeutics in Oncology

Brunie Felding

Immunotherapy: open access,, 2016

View PDFchevron_right

State of the art in anti-cancer mAbs

Alejandrina Vendrell

Journal of Biomedical Science, 2017

View PDFchevron_right

Developments and Challenges for mAb-Based Therapeutics

Sumit Goswami

Antibodies, 2013

View PDFchevron_right

Monoclonal Antibody Therapy for Cancer

Grégory ADAMS

Annual Review of Medicine, 2003

View PDFchevron_right

Monoclonal Antibodies in Cancer Therapy

Klaus Pfizenmaier

Current Medicinal Chemistry-Anti-Cancer Agents, 2004

View PDFchevron_right

New approaches to antibody therapy

Grégory ADAMS

Oncogene, 2000

View PDFchevron_right

Therapeutic Monoclonal Antibodies: Future Prospectives

HamdAllah Hafez Aly Zidan

Journal of Cancer Immunology, 2021

View PDFchevron_right

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy

Jérôme Galon, Alexander Eggermont

Oncoimmunology, 2014

View PDFchevron_right

Monoclonal Antibodies (mAbs) Approved for Cancer Treatment in the 2020s

Abdolkarim Sheikhi

Trends in Medical Sciences, 2021

View PDFchevron_right

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy

Jérôme Galon, Alexander Eggermont

Oncoimmunology, 2014

View PDFchevron_right

Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review X

Francesca Levi-schaffer

British Journal of Pharmacology, 2016

View PDFchevron_right

Developments in therapy with monoclonal antibodies and related proteins

Gail Phillips

Clinical medicine (London, England), 2017

View PDFchevron_right

The Current Landscape of Antibody-based Therapies in Solid Malignancies

Maneesh Jain

Theranostics, 2021

View PDFchevron_right

Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging

Carlos Manterola

Biomedicines

View PDFchevron_right

Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications

Jérôme Galon

Oncoimmunology, 2015

View PDFchevron_right

Safety and Tolerability of Antibody-Drug Conjugates in Cancer

Anna Wolska

Drug Safety, 2019

View PDFchevron_right

Trial Watch: Monoclonal antibodies in cancer therapy

jessica Zucman-Rossi

OncoImmunology, 2012

View PDFchevron_right

Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario

Francesco Passiglia, Viviana Bazan, Antonio Galvano

Expert Opinion on Biological Therapy, 2015

View PDFchevron_right

Monoclonal Antibody in Quest of Cancer Therapeutics

abdullah saeed

View PDFchevron_right

Therapeutic antibodies: successes, limitations and hopes for the future

Patrick Chames

British Journal of Pharmacology, 2009

View PDFchevron_right

Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia

Natarajan Muthusamy

mAbs, 2014

View PDFchevron_right

Innovative Therapy, Monoclonal Antibodies and Beyond

Matteo Bellone

Cytokine & Growth Factor Reviews, 2017

View PDFchevron_right

A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Pooja Dhupkar

Molecular Cancer Therapeutics, 2014

View PDFchevron_right